stella
beta
A Phase II Trial of Tebentafusp in HLA-A*02:01 Positive Patients With Advanced Clear Cell Sarcoma — Stella
Recruiting
Back to HLA-A*0201 Positive Cells Present trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(2 sites)
United States
University of Southern California - Norris Cancer Center, Los Angeles, California
Memorial Sloan Kettering Cancer Center, New York, New York
View full record on ClinicalTrials.gov